Tag: Phase IIIb

Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque Psoriasis

Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque Psoriasis

| May 1, 2018

by Saakshi Khattri, MD; Orin Goldblum, MD; Kathleen Solotkin, MSN; Yasmin Amir, MD; Michelle S. Min, MD, MSci; Terri Ridenour, BSN, MBA; Fan Emily Yang, PhD; and Mark Lebwohl, MD, FAAD Dr. Khattri, Dr. Amir, Dr. Min, and Dr. Lebwohl are with the Department of Dermatology at the Icahn School of Medicine at Mount Sinai […]

Continue Reading